SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-200020"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-200020" > Multimorbidity in p...

  • Gerhardt, TeresaIcahn Sch Med Mt Sinai, NY USA; Deutsch Herzzentrum Charite, Germany; Berlin Inst Hlth, Germany; DZHK German Ctr Cardiovasc Res, Germany (författare)

Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • ELSEVIER SCI LTD,2023
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-200020
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-200020URI
  • https://doi.org/10.1016/S2214-109X(23)00408-4DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|Novartis Pharma; Forderkreis der Dresdner Herz-Kreislauf-Tage; German Center for Cardiovascular Research; German Research Foundation (DFG) [GE 3588/1-1, GE 3179/1-1]; German Society of Internal Medicine; National University of Singapore; Ministry of Education; National Medical Research Council
  • Background Multimorbidity (two or more comorbidities) is common among patients with acute heart failure, but comprehensive global information on its prevalence and clinical consequences across different world regions and income levels is scarce. This study aimed to investigate the prevalence of multimorbidity and its effect on pharmacotherapy and prognosis in participants of the REPORT-HF study.Methods REPORT-HF was a prospective, multicentre, global cohort study that enrolled adults (aged >= 18 years) admitted to hospital with a primary diagnosis of acute heart failure from 358 hospitals in 44 countries on six continents. Patients who currently or recently participated in a clinical treatment trial were excluded. Follow-up data were collected at 1-year post-discharge. The primary outcome was 1-year post-discharge mortality. All patients in the REPORT-HF cohort with full data on comorbidities were eligible for the present study. We stratified patients according to the number of comorbidities, and countries by world region and country income level. We used one-way ANOVA, chi(2) test, or Mann-Whitney U test for comparisons between groups, as applicable, and Cox regression to analyse the association between multimorbidity and 1-year mortality.Findings Between July 23, 2014, and March 24, 2017, 18 553 patients were included in the REPORT-HF study. Of these, 18 528 patients had full data on comorbidities, of whom 11 360 (61%) were men and 7168 (39%) were women. Prevalence rates of multimorbidity were lowest in southeast Asia (72%) and highest in North America (92%). Fewer patients from lower-middle-income countries had multimorbidity than patients from high-income countries (73% vs 85%, p<0 center dot 0001). With increasing comorbidity burden, patients received fewer guideline-directed heart failure medications, yet more drugs potentially causing or worsening heart failure. Having more comorbidities was associated with worse outcomes: 1-year mortality increased from 13% (no comorbidities) to 26% (five or more comorbidities). This finding was independent of common baseline risk factors, including age and sex. The population-attributable fraction of multimorbidity for mortality was higher in high-income countries than in upper-middle-income or lower-middle-income countries (for patients with five or more comorbidities: 61% vs 27% and 31%, respectively).Interpretation Multimorbidity is highly prevalent among patients with acute heart failure across world regions, especially in high-income countries, and is associated with higher mortality, less prescription of guideline-directed heart failure pharmacotherapy, and increased use of potentially harmful medications.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Gerhardt, Louisa M. S.Heidelberg Univ, Germany (författare)
  • Ouwerkerk, WouterNatl Heart Ctr, Singapore; Univ Amsterdam, Netherlands (författare)
  • Roth, Gregory A.Univ Washington, WA USA; Univ Washington, WA USA; Univ Hosp Wurzburg, Germany (författare)
  • Dickstein, KennethUniv Bergen, Norway (författare)
  • Collins, Sean P.Vanderbilt Univ, TN USA; Vet Affairs Tennessee Valley Healthcare Syst, TN USA (författare)
  • Cleland, John G. F.Univ Glasgow, Scotland; Imperial Coll London, England (författare)
  • Dahlström, UlfLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)ulfda85 (författare)
  • Tay, Wan TingNatl Heart Ctr, Singapore (författare)
  • Ertl, GeorgUniv Wuzburg, Germany; Univ Hosp Wurzburg, Germany (författare)
  • Hassanein, MahmoudAlexandria Univ, Egypt (författare)
  • Perrone, Sergio VUniv Catolica Argentina, Argentina (författare)
  • Ghadanfar, MathieuM Ghadanfar Consulting Life Sci, Switzerland (författare)
  • Schweizer, AnjaNovartis Pharm, Switzerland (författare)
  • Obergfell, AchimNovartis Pharm, Switzerland (författare)
  • Filippatos, GerasimosUniv Cyprus, Cyprus; Natl & Kapodistrian Univ Athens, Greece (författare)
  • Lam, Carolyn S. P.Natl Heart Ctr, Singapore; Duke Natl Univ Singapore, Singapore; Univ Groningen, Netherlands (författare)
  • Tromp, JasperDuke Natl Univ Singapore, Singapore; Natl Univ Singapore, Singapore; Natl Univ Hlth Syst, Singapore (författare)
  • Angermann, Christiane E.Univ Wuzburg, Germany; Univ Hosp Wurzburg, Germany; Univ Hosp Wurzburg, Germany; Univ Wurzburg, Germany; Univ Hosp Wurzburg, Germany (författare)
  • Icahn Sch Med Mt Sinai, NY USA; Deutsch Herzzentrum Charite, Germany; Berlin Inst Hlth, Germany; DZHK German Ctr Cardiovasc Res, GermanyHeidelberg Univ, Germany (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:The Lancet Global Health: ELSEVIER SCI LTD11:12, s. e1874-e18842214-109X

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy